Taiwan is spending NT$24 billion on its National Drug Resilience Preparedness Plan. But does bringing factories home actually make a supply chain resilient? Starting from a counterintuitive EU study, I argue that real resilience lives in the flow of information, and that this is not just a pharma problem but one every manufacturer in Taiwan shares.
Got it. We will contact you within one business day.
Something went wrong. Please try again later or email service@oakmega.com.